The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of food access and poverty on somatic genomic profiles and clinical outcomes in metastatic breast cancer.
 
Emily Podany
No Relationships to Disclose
 
Lorenzo Foffano
No Relationships to Disclose
 
Nitin Katakam
No Relationships to Disclose
 
Arielle Medford
Consulting or Advisory Role - AstraZeneca; Edgewood Oncology; Guardant Health; Illumina; Myriad Genetics; Natera; Novartis; Science for America
Speakers' Bureau - Natera
Research Funding - AstraZeneca (Inst)
 
Brenno Pastò
Travel, Accommodations, Expenses - Lilly
 
Natalie Heater
No Relationships to Disclose
 
Olivia Rieur
No Relationships to Disclose
 
Ashrit Challa
No Relationships to Disclose
 
Diana Jaber
No Relationships to Disclose
 
Eleonora Nicolò
No Relationships to Disclose
 
Carolina Reduzzi
Research Funding - Menarini Silicon Biosystems (Inst)
 
Marla Lipsyc-Sharf
Honoraria - Exact Sciences; Natera; Novartis
Consulting or Advisory Role - Exact Sciences; Guardant Health; Lilly; Natera; Novartis; Stemline Therapeutics; Tersera
Speakers' Bureau - Lilly
Research Funding - Bridgebio; Natera; Stemline Therapeutics
Travel, Accommodations, Expenses - Exact Sciences; Lilly; Natera
 
Shaili Tapiavala
No Relationships to Disclose
 
William Gradishar
Consulting or Advisory Role - AstraZeneca; Genentech/Roche; Gilead Sciences; merck; Novartis; Pfizer
 
Fabio Puglisi
Honoraria - AstraZeneca; Bayer; Daiichi Sankyo; Exact Sciences; Gilead Sciences; Ipsen; Italfarmaco; Lilly; Menarini; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Seagen
Research Funding - AstraZeneca; Eisai; Roche
 
Aditya Bardia
Consulting or Advisory Role - Alyssum; Daiichi Sankyo/Astra Zeneca; Genentech; Genentech/Roche (Inst); Gilead Sciences; Gilead Sciences (Inst); Innocrin Pharma (Inst); Lilly; Lilly (Inst); Menarini; Menarini (Inst); Merck; Mersana; Novartis; Novartis (Inst); Pfizer; Pfizer (Inst); Radius Health (Inst); Sanofi
Research Funding - AstraZeneca/Daiichi Sankyo (Inst); Genentech (Inst); Immunomedics (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Radius Health (Inst); Sanofi (Inst)
 
Massimo Cristofanilli
Honoraria - AstraZeneca; Datar Cancer Genetics; Guardant Health; Lilly; Menarini Silicon Biosystems; Novartis; Pfizer
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Lilly; Menarini
Research Funding - Angle; AstraZeneca; Lilly; Menarini Silicon Biosystems; Merck
 
Cynthia Ma
Consulting or Advisory Role - AstraZeneca; Bayer; Biovica; Daiichi Sankyo/Astra Zeneca; Delphi Diagnostics; FoRx; Foundation Medicine; Lilly; Merck; Novartis; Olaris; Pathlight; Pfizer; Puma Biotechnology; Regor Therapeutics Group; Stemline Therapeutics; Stemline Therapeutics; Tempus
Research Funding - Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate: Authorship - served as a co-author on the subject of endocrine therapy for metastatic breast cancer and receive compensation as an author, less than a few hundred dollars a year. It does not affect my patient care or research.
 
Lorenzo Gerratana
Consulting or Advisory Role - Abbvie; AstraZeneca; Daiichi Sankyo Europe GmbH; GlaxoSmithKline; Incyte; Lilly; Menarini Group; Merck Sharp & Dohme; Novartis; Pfizer
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - Gilead Sciences; Menarini Group; Novartis
 
Andrew Davis
Consulting or Advisory Role - bioTheranostics; Pfizer